Thursday, May 18, 2017

#Cannabis Stock News Update: MariMed ($MRMD) Q1 Revenue Doubles, Cannabis Services and Products Business Growing

#Cannabis Stock News Update: MariMed ($MRMD) Q1 Revenue Doubles, Cannabis Services and Products Business Growing

BOSTON - May 18, 2017 (Investorideas.com Newswire) MariMed Inc. (MRMD) has over the past few years quietly developed its client base and revenue in the legal cannabis industry. Management anticipates MariMed will be on an even faster growth trajectory as many of its projects will be coming to fruition. MariMed reported strong revenue growth for 2016, which has continued into 2017. MariMed Inc. revenue for the three months ended March 31, 2017 was $1,150,719, nearly double the revenue of $614,456 for the comparable quarter 2016. MariMed more than doubled revenue in 2016 over 2015, increasing from $1.27 million in 2015 to $3.56 million in 2016. Substantially all the revenue was attributable to its subsidiary MariMed Advisors and its cannabis services and products business.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.